Overview
Anna Zolyan is a Neurologist in Dallas, Texas. Her top areas of expertise are Seizures, Epilepsy, CACH Syndrome, and Neurotoxicity Syndromes.
Her clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1717 Main St Ste 5850, Dallas, TX 75201
2827 Fort Missoula Rd, Missoula, MT 59804
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Texas Southwestern Medical Center
Benjamin Greenberg is a Neurologist in Dallas, Texas. Dr. Greenberg is highly rated in 19 conditions, according to our data. His top areas of expertise are Transverse Myelitis, Optic Neuritis, Neuromyelitis Optica, and Multiple Sclerosis (MS).
Texas Scottish Rite Hospital For Children
Charuta Joshi is a Neurologist in Dallas, Texas. Dr. Joshi is highly rated in 28 conditions, according to our data. Her top areas of expertise are Epilepsy, Seizures, West Syndrome, Lennox-Gastaut Syndrome (LGS), and Deep Brain Stimulation.
Texas Neurology, P.A.
Dr. Schiffmann is a renowned expert on neurometabolic diseases. He earned his medical degree from the University of Liège, Belgium and a Master of Health Sciences in Clinical Research from Duke University. He is board-certified in Neurology with a Special Qualification in Child Neurology and is a Fellow of the American Academy of Neurology. Dr. Schiffmann was a lead researcher at the United States National Institutes of Health in Bethesda, Maryland for over 17 years (1991-2007) and then the Director of the Institute of Metabolic Disease at the Baylor Scott & White Research Institute in Dallas, Texas, 2008-2019. Dr. Schiffmann is a Professor in the Department of Internal Medicine, Texas Christian University and a Clinical Professor, Texas A&M University Medical School College of Medicine. He is also a Senior Vice President for Clinical Research at 4D Molecular Therapeutics. Dr. Schiffmann has been performing pre-clinical and clinical research on lysosomal storage diseases since 1991 with a special focus on the natural history, pathogenesis and therapy of Fabry disease, Gaucher disease and the leukodystrophies. One of his particular interests and areas of expertise is to address patients with undiagnosed neurological diseases. Dr. Schiffmann has published 276 peer-reviewed research articles and over 15 book chapters. Dr. Schiffmann is highly rated in 10 conditions, according to our data. His top areas of expertise are Gaucher Disease Type 3, Fabry Disease, Gaucher Disease, and Leukodystrophy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CACH SyndromeDr. Zolyan isExperienced. Learn about CACH Syndrome.
- EpilepsyDr. Zolyan isExperienced. Learn about Epilepsy.
- Neurotoxicity SyndromesDr. Zolyan isExperienced. Learn about Neurotoxicity Syndromes.
- SeizuresDr. Zolyan isExperienced. Learn about Seizures.